Relief Therapeutics Holding Stock Cash Per Share
| RLFTF Stock | USD 4.33 0.13 2.91% |
Relief Therapeutics Holding fundamentals help investors to digest information that contributes to Relief Therapeutics' financial success or failures. It also enables traders to predict the movement of Relief OTC Stock. The fundamental analysis module provides a way to measure Relief Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Relief Therapeutics otc stock.
Relief |
Relief Therapeutics Holding OTC Stock Cash Per Share Analysis
Relief Therapeutics' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Relief Therapeutics Cash Per Share | 0.01 X |
Most of Relief Therapeutics' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Relief Therapeutics Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Relief Therapeutics Holding has a Cash Per Share of 0.01 times. This is 99.77% lower than that of the Healthcare sector and 99.77% lower than that of the Biotechnology industry. The cash per share for all United States stocks is 99.8% higher than that of the company.
Relief Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Relief Therapeutics' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Relief Therapeutics could also be used in its relative valuation, which is a method of valuing Relief Therapeutics by comparing valuation metrics of similar companies.Relief Therapeutics is currently under evaluation in cash per share category among its peers.
Relief Fundamentals
| Return On Equity | -0.33 | |||
| Return On Asset | -0.12 | |||
| Operating Margin | (5.96) % | |||
| Current Valuation | 102.36 M | |||
| Shares Outstanding | 4.39 B | |||
| Shares Owned By Insiders | 3.68 % | |||
| Shares Owned By Institutions | 22.16 % | |||
| Price To Book | 0.70 X | |||
| Price To Sales | 22.16 X | |||
| Revenue | 3.32 M | |||
| Gross Profit | 2.57 M | |||
| EBITDA | (33.3 M) | |||
| Net Income | (34.7 M) | |||
| Cash And Equivalents | 29.87 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 396 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 2.80 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (35.72 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 10 | |||
| Beta | -13.71 | |||
| Market Capitalization | 120.99 M | |||
| Total Asset | 251.62 M | |||
| Net Asset | 251.62 M |
About Relief Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Relief Therapeutics Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Relief Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Relief Therapeutics Holding based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Relief OTC Stock
Relief Therapeutics financial ratios help investors to determine whether Relief OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Relief with respect to the benefits of owning Relief Therapeutics security.